Improving fairness in glaucoma risk estimation using artificial intelligence
Achieving Model Fairness on Automatic Primary Open-angle Glaucoma Screening
['FUNDING_R21'] · WEILL MEDICAL COLL OF CORNELL UNIV · NIH-10726928
This study is working on a new AI tool to help better predict the risk of glaucoma, especially for people in diverse communities like African and Hispanic Americans, so that everyone can get fairer and more accurate eye care.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WEILL MEDICAL COLL OF CORNELL UNIV (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-10726928 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a new artificial intelligence model to better estimate the risk of primary open-angle glaucoma (POAG), particularly in diverse populations such as African and Hispanic Americans. The project aims to address potential biases in existing predictive models that may lead to unequal healthcare outcomes. By utilizing innovative methodologies, the researchers will validate their approach without relying on demographically balanced datasets, ensuring a more equitable assessment of glaucoma risk. Patients may benefit from improved screening processes that are fairer and more accurate.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for primary open-angle glaucoma, particularly those from African and Hispanic American backgrounds.
Not a fit: Patients who do not have risk factors for primary open-angle glaucoma may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate glaucoma risk assessments, ultimately preventing vision loss in at-risk populations.
How similar studies have performed: Other research has shown promise in using artificial intelligence to address biases in healthcare, making this approach both relevant and potentially impactful.
Where this research is happening
NEW YORK, UNITED STATES
- WEILL MEDICAL COLL OF CORNELL UNIV — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PENG, YIFAN — WEILL MEDICAL COLL OF CORNELL UNIV
- Study coordinator: PENG, YIFAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.